mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.06 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.091 |
0.07 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |